Please login to the form below

Not currently logged in
Email:
Password:

Future pharma

This page shows the latest Future pharma news and features for those working in and with pharma, biotech and healthcare.

Bayer's drop of the future

Bayer's drop of the future

Well, because they are really good examples of – and therefore evidence of – industry phenomena that I observed and predicted, first in my 2011 book ‘The Future of Pharma’ and then its ... The future shaper. Firstly, I wrote about the rising

Latest news

More from news
Approximately 0 fully matching, plus 144 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    Figure 1. As Neils Bohr famously joked, predictions are difficult, especially about the future. ... But can we use science to predict the future of our whole industry?

  • The promise of precision medicine The promise of precision medicine

    The future of pharma. Drug metabolism rates vary between patients. Some patients metabolise a drug so rapidly that therapeutically effective blood and tissue concentrations are not reached; in others, metabolism may ... We are still in the early stages,

  • Transforming clinical trial data into a long-term asset Transforming clinical trial data into a long-term asset

    Considering the future of the trial master file in the light of COVID-19 and accelerated digital transformation. ... On the contrary, it has an important part to play in pharma’s future.

  • The Brexit clock is counting down and time is running out The Brexit clock is counting down and time is running out

    Consider future business trips. Pharma businesses will be used to their European colleagues coming across to the UK and British nationals travelling to Europe – for example, to collaborate on projects for ... Frontier workers. Pharma businesses may

  • After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream

    Seen as the future of pharma for many years, cell and gene therapy (C&GT) is finally coming of age – advances in technology and new commercial viability mean we are closer ... hangover of big pharma being left behind in the sphere of monoclonal

More from intelligence
Approximately 0 fully matching, plus 57 partially matching documents found.

Latest appointments

  • Leo Pharma appoints new senior vice president Leo Pharma appoints new senior vice president

    Gitte Aabo, president and chief executive officer of Leo Pharma, said: “Rhonda has extensive experience in pharmaceutical supply chain management, and she knows Leo Pharma really well. ... Duffy initially joined Leo Pharma back in 1993 and was

  • Future Thinking appoints Mohamed Muhsin as UK pharma head Future Thinking appoints Mohamed Muhsin as UK pharma head

    I’m delighted to be joining Future Thinking and helping its clients navigate the opportunities and challenges that lie ahead for the sector.”. ... Working with Future Thinking is a great oppitunity to help healthcare organisations deliver the best

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    and management experience, which will be an invaluable asset for PLx Pharma's success and future growth prospects. ... Giordano said: “I am excited to be joining PLx Pharma at this critical pre-launch inflection point.”.

  • EUSA Pharma founder to chair Glide Pharma EUSA Pharma founder to chair Glide Pharma

    Morton was most recently chief executive at oncology specialist EUSA Pharma – a company he also founded. ... Commenting on the future of Glide Pharma under his direction Morton said: "Having completed a significant investment round earlier this year

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Future-Proofing Healthcare and Medicine

    Bogi Eliasen, Director of Health at Copenhagen Institute for Futures Studies, discusses the future of genomics, personalized health, healthcare data, digital health, and more.

  • Let's Learn Digital

    Our purpose is to design remote educatation and learning programs that orientate Pharma clients and agencies around the future potential of digital and emerging technologies for a post pandemic world.

  • The Future of Wearable and Implantable Devices

    Nance Dicciani &  Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder &CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices. Among many other things, we

  • Covid-19 redefines rules of customer engagement

    Looking to the future, even when the pandemic is over, there is a sense that pharma’s style of engagement with the NHS has already changed forever. ... However, it is clear that digital is the future for HCPs, patients and pharma alike and that

  • Using Artificial Intelligence to Transform Pharma

    Andree Bates, Founder &CEO of Eularis, and discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. ... Among many other interesting topics, they dissect the

More from PMHub
Approximately 3 fully matching, plus 39 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....